EWG Elevate’s Teladoc Health TDOC Stock Holding History

EWG Elevate’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-210	Closed	-$4.97K	–	700
2022 Q4	$4.97K	Buy	+210	New	+$5.66K	﹤0.01%	470

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

SOMRS

State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EWG Elevate's TDOC Position: Q1 2023 in Review

EWG Elevate sold out of Teladoc Health (TDOC) in Q1 2023, closing a stake of 210 shares — an estimated $4.97K sold.

EWG Elevate first reported a position in TDOC in Q4 2022 and held it in 1 quarter. The position peaked at $4.97K in Q4 2022. 429 funds tracked by Wall St. Rank hold TDOC as of Q1 2023.

EWG Elevate reported no remaining Teladoc Health position as of Q1 2023 after selling out during the quarter.
EWG Elevate sold 210 Teladoc Health shares in Q1 2023, an estimated $4.97K.
EWG Elevate first reported a position in Teladoc Health in Q4 2022 and held it in 1 quarter.
EWG Elevate's Teladoc Health position peaked at $4.97K in Q4 2022.
429 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2023.

Based on EWG Elevate's 13F filing for Q1 2023, filed 13 Apr 2023.